Somewhere in the United States, a nurse practitioner named — let's call her "Jessica" — is licensed in 34 states, credentialed at six different telehealth platforms, and has written close to 12,000 GLP-1 prescriptions in the last year. She has never met a single one of those patients. She reviews intake forms in batches between her two kids' school pickups.
Jessica is not a hypothetical. Patterns like hers show up in state medical board records, LinkedIn, and in the names that quietly appear at the bottom of every prescription emailed out of a compounded-GLP-1 pharmacy. This is how the business actually runs.
Why nurse practitioners, not physicians
The core reason is simple: cost and capacity. A physician's time on an async platform costs roughly $3–5 per intake. A nurse practitioner's costs $1–2. In a high-volume subscription business, that spread is the difference between profitable and not.
Nurse practitioners also have something physicians mostly don't: unrestricted practice authority in roughly two dozen states, meaning they can prescribe without physician supervision. For a multi-state telehealth platform, that's gold. Recruit a handful of NPs, get them licensed in the right combination of states, and you can cover most of the country with a tiny clinical team.
The "licensed in 50 states" claim
Many platforms advertise clinicians who are "licensed in all 50 states." This is plausible but uncommon, and it tells you something: the clinician has built a career around multi-state telehealth rather than in-person practice. There's nothing wrong with that. But a 50-state NP is, by definition, not seeing patients in person anywhere.
The process of getting licensed in multiple states involves applications, background checks, CEU requirements, and $100–500 per state in fees — usually paid by the platform. The Interstate Medical Licensure Compact and the Nurse Licensure Compact speed this up, but most compact states still require a separate application for NPs doing telehealth across state lines.
How to look up the clinician on your prescription
Every prescription has a prescriber name and an NPI (National Provider Identifier) number. By federal law, that information has to be on the label or the associated paperwork. Once you have it, everything else is public.
- Find the NPI. Look on your prescription label, your shipping paperwork, or any "after-visit summary" document emailed to you.
- Look it up. The CMS NPI Registry is free and public. Enter the NPI and you'll get the clinician's name, credentials, practice address on record, and specialty.
- Cross-check the state license. Every state has a public license lookup. Search "[state] nurse practitioner license verification." Enter the clinician's name. You'll see their license number, status (active/expired/disciplined), and any board actions.
The five patterns that matter
After running dozens of NP lookups across GLP-1 platforms, five patterns are worth flagging:
1. The 50-state unicorn
A single NP licensed in every state. Almost always means the platform is a small operation riding on one prolific prescriber. If that NP gets sick, goes on vacation, or has a board action, your prescriptions stop.
2. The P.O. box practice address
The NPI registry lists a practice address. If it's a registered agent, a UPS store, or a coworking space in a state with no medical board activity (Delaware, Wyoming), that's a structural tell.
3. The recent graduate at scale
Nothing wrong with new NPs. But an NP who graduated less than three years ago and is credentialed at six telehealth platforms prescribing thousands of GLP-1 doses per month is, at minimum, not a pattern the nursing boards designed for.
4. The "medical director" who isn't in the NPI database for your state
Platforms often feature a medical director in their marketing — "Dr. X, MD, oversees all prescriptions." Check whether Dr. X has an NPI license in the state your prescription was written in. If not, they're not prescribing for you. They're a marketing asset.
5. The ghost panel
Some platforms don't disclose the clinician on the prescription label, instead listing the platform's name. Look at your actual paperwork — the PDF confirmation, the after-visit summary — the NPI is on there somewhere. If it truly isn't anywhere, that's a federal labeling issue worth asking your pharmacy about directly.
What a good clinician setup looks like
- Transparent panel. The platform publishes clinician names and credentials somewhere on the site, not just faceless "licensed providers."
- Reasonable volume per clinician. A team of 10 NPs writing 400 prescriptions a month each = ~4,000 patients. A team of 2 NPs writing 6,000 each = red flag.
- Supervision or consultation chain. Even in full-practice-authority states, good platforms have physician consultants available for complex cases.
- Active licenses in your state specifically. Not just "we operate in your state" — the specific NP signing your prescription has an active license there.
The awkward truth about NP scale
The nurse practitioner profession didn't anticipate a world where a single licensee would sign 12,000 prescriptions a year for patients they'd never met. The scope-of-practice rules were written for clinic settings. The telehealth economy stretches those rules to their structural limit — legally, usually, but clinically in ways that haven't been studied at scale.
None of this makes NP-led async prescribing illegitimate. It makes it a model that works really well for the right patient and really poorly for the wrong one. The individual NP isn't the problem. The volume is.
Looking for a platform that shows its work?
Synergy Rx and Care Bare Rx are the two platforms that scored highest on our transparency audit — they disclose pharmacies, clinicians, and titration protocols up front.
See Synergy Rx → Compare Care Bare Rx